Mucopolysaccharidosis Type I: Current Treatments,Limitations and Prospects for Improvement

Mucopolysaccharidosis Type I: Current Treatments,Limitations and Prospects for Improvement

Mucopolysaccharidosis type I (MPS I) is a lysosomal disease, caused by a deficiency of the enzyme alpha-L-iduronidase (IDUA). IDUA catalyzes the degradation of the glycosaminoglycans dermatan and heparan sulfate (DS and HS, respectively). Lack of the enzyme leads to pathologic accumulation of undegr...

Full description

Bibliographic Details
Main Authors:	Christiane S. Hampe, Jacob Wesley, Troy C. Lund, Paul J. Orchard, Lynda E. Polgreen, Julie B. Eisengart, Linda K. McLoon, Sebahattin Cureoglu, Patricia Schachern, R. Scott McIvor
Format:	Article
Language:	English
Published:	MDPI AG 2021-01-01
Series:	Biomolecules
Subjects:	mucopolysaccharidosis type I Hurler syndrome enzyme replacement therapy hematopoietic stem cell transplantations animal models experimental therapies
Online Access:	https://www.mdpi.com/2218-273X/11/2/189

Similar Items

Mucopolysaccharidosis Type I
by: Francyne Kubaski, et al.
Published: (2020-03-01)

Biomarkers for prediction of skeletal disease progression in mucopolysaccharidosis type I
by: Troy C. Lund, et al.
Published: (2021-03-01)

Orthopedic Pathology in Children with Mucopolysaccharidosis Type I
by: Nato D. Vashakmadze, et al.
Published: (2016-12-01)

Open issues in Mucopolysaccharidosis type I-Hurler
by: Rossella Parini, et al.
Published: (2017-06-01)

Elements of lentiviral vector design toward gene therapy for treating mucopolysaccharidosis I
by: Li Ou, et al.
Published: (2016-09-01)

“Growth patterns in children with mucopolysaccharidosis type I-Hurler after hematopoietic stem cell transplantation: Comparison with untreated patients”
by: Alessandro Cattoni, et al.
Published: (2021-09-01)

Immune tolerance induction for laronidase treatment in mucopolysaccharidosis I
by: Roberto Giugliani, et al.
Published: (2017-03-01)

Enzyme Replacement Therapy and Hematopoietic Stem Cell Transplantation Results in Patients with Hurler Syndrome: Clinical Cases
by: Nato D. Vashakmadze, et al.
Published: (2019-09-01)

Lower Exposure to Busulfan Allows for Stable Engraftment of Donor Hematopoietic Stem Cells in Children with Mucopolysaccharidosis Type I: A Case Report of Four Patients
by: Praveen Shukla, et al.
Published: (2020-08-01)

Mucopolysaccharidosis Type I: A Review of the Natural History and Molecular Pathology
by: Christiane S. Hampe, et al.
Published: (2020-08-01)

Direct gene transfer to the CNS prevents emergence of neurologic disease in a murine model of mucopolysaccharidosis type I
by: Daniel A. Wolf, et al.
Published: (2011-07-01)

A case report of a patient with mucopolysaccharidosis type II
by: M.R. Rivera Vega, et al.
Published: (2017-04-01)

Evaluation of Demographic and Clinical Characteristics of Patients with Mucopolysaccharidosis
by: Pelin Teke Kısa, et al.
Published: (2017-06-01)

An online survey on burden of illness among families with post-stem cell transplant mucopolysaccharidosis type I children in the United States
by: Therese Conner, et al.
Published: (2019-02-01)

Diagnostic Difficulties of Mucopolysaccharidosis Type I Mild Forms: Clinical Cases
by: Nato D. Vashakmadze, et al.
Published: (2020-06-01)

Rare cases of mucopolysaccharidosis type I in children with Hurler and Hurler-Scheie syndromes
by: A. E. Babushkin, et al.
Published: (2018-10-01)

MODERN APPROACHES TO THERAPY FOR CHILDREN WITH MUCOPOLYSACCHARIDOSIS
by: N. V. Buchinskaya, et al.
Published: (2014-05-01)

Evaluation of Multiple Methods for Quantification of Glycosaminoaminoglycan Biomarkers in Newborn Dried Blood Spots from Patients with Severe and Attenuated Mucopolysaccharidosis-I
by: Zackary M. Herbst, et al.
Published: (2020-08-01)

Mucopolysaccharidosis I, II, and VI: brief review and guidelines for treatment
by: Roberto Giugliani, et al.
Published: (2010-01-01)

Long-term evolution of mucopolysaccharidosis type I in twins treated with enzyme replacement therapy plus hematopoietic stem cells transplantation
by: Luis M. Carbajal-Rodríguez, et al.
Published: (2021-08-01)

The hematopoietic stem cell transplantation in children with Hurler syndrome
by: S. Ya. Volgina, et al.
Published: (2019-11-01)

Cardiac features and effects of enzyme replacement therapy in Taiwanese patients with Mucopolysaccharidosis IVA
by: Hsiang-Yu Lin, et al.
Published: (2018-08-01)

Damages of Cardiovascular System at Mucopolysaccharidosis Type I: Clinical Cases
by: Elena S. Vasichkina, et al.
Published: (2020-01-01)

Aortic Root Dilatation in Mucopolysaccharidosis I–VII
by: Meena Bolourchi, et al.
Published: (2016-11-01)

Differences in MPS I and MPS II Disease Manifestations
by: Christiane S. Hampe, et al.
Published: (2021-07-01)

Genotypic and bioinformatic evaluation of the alpha-l-iduronidase gene and protein in patients with mucopolysaccharidosis type I from Colombia, Ecuador and Peru
by: Tatiana Pineda, et al.
Published: (2014-01-01)

Experience of Idursulfase Beta Administration in the Child with Mucopolysaccharidosis Type II: Clinical Case
by: Tatiana K. Kruchina, et al.
Published: (2020-12-01)

Respiratory Dysfunction in Children and Adolescents with Mucopolysaccharidosis Types I, II, IVA, and VI
by: Assel Tulebayeva, et al.
Published: (2020-01-01)

Hurler–Scheie syndrome in Niger: a case series
by: Hamid Assadeck, et al.
Published: (2019-04-01)

Mucopolisacaridosis (síndrome de Hunter)
by: Xidix Toirac Cabrera, et al.

Anesthetic management in children with Hurler′s syndrome undergoing emergency ventriculoperitoneal shunt surgery
by: Nidhi Gupta, et al.
Published: (2012-01-01)

Enzyme replacement therapy in Hurler syndrome after failure of hematopoietic transplant
by: Leonor Arranz, et al.
Published: (2015-06-01)

Visual Dysfunction of Type I and VI Mucopolysaccharidosis Patients Evaluated with Visual Evoked Cortical Potential
by: Bruno Duarte Gomes, et al.
Published: (2012-03-01)

Cardiac manifestations and effects of enzyme replacement therapy for over 10 years in adults with the attenuated form of mucopolysaccharidosis type I
by: Kenta Sugiura, et al.
Published: (2020-12-01)

Bull's eye maculopathy and subfoveal deposition in two mucopolysaccharidosis type I patients on long-term enzyme replacement therapy
by: Heather G. Mack, et al.
Published: (2018-03-01)

Incidental diagnosis of mucopolysaccharidosis type I in an infant with chronic intestinal pseudoobstruction by exome sequencing
by: Auriane Cospain, et al.
Published: (2020-09-01)

EFFICACY AND SAFETY OF ENZYME REPLACEMENT THERAPY IN CHILDREN WITH MUCOPOLYSACCHARIDOSIS TYPE I, II, AND VI: A SINGLE-CENTER COHORT STUDY
by: Liliia A. Osipova, et al.
Published: (2018-04-01)

Diagnostic journey and impact of enzyme replacement therapy for mucopolysaccharidosis IVA: a sibling control study
by: Can Ficicioglu, et al.
Published: (2020-11-01)

Role of elosulfase alfa in mucopolysaccharidosis IVA
by: Regier DS, et al.
Published: (2016-06-01)

Mucopolysaccharidosis type II: Enzyme Replacement Therapy Efficiency
by: Nato D. Vashakmadze, et al.
Published: (2020-02-01)